Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Investor Wire

CASI Quote, Trading Chart, CASI Pharmaceuticals Inc.


home / stock / casi / casi quote

$ Last:

Change Percent:

$ Open:

$ Previous Close:

$ High:

$ Low:

0 Volume:

01/01/1970 12:00:00 am Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Last Five Trading Days

Stock DateOpen PriceClose PriceHighLowVolume
2021-03-052.182.272.412.0702332,021
2021-03-042.362.182.422.1353,359
2021-03-032.452.392.52952.37208,643
2021-03-022.642.472.672.4360,604
2021-03-012.592.542.592.46246,825
2021-02-262.542.462.542.42288,434
2021-02-252.662.492.662.48356,641
2021-02-242.692.652.832.54391,533
2021-02-232.72.542.72.46547,912
2021-02-222.832.742.842.74248,381
2021-02-192.792.792.922.75363,071
2021-02-182.862.792.8782.75281,627
2021-02-172.862.882.942.77439,010
2021-02-162.982.833.012.8563,677
2021-02-153.032.893.032.731,189,505
2021-02-123.032.893.032.731,189,163
2021-02-113.1133.243501,145
2021-02-103.363.23.43.01629,988
2021-02-093.43.343.473.31431,802
2021-02-083.53.43.523.3749,612
Stock Information

CASI Pharmaceuticals Inc. Company Name:

CASI Stock Symbol:

NASDAQ Market:

CASI Pharmaceuticals Inc. Website:

CASI Quote, Trading Chart, CASI Pharmaceuticals Inc.

MENU
CASI CASI Quote CASI Short CASI News CASI Articles CASI Message Board
Get CASI Alerts

News, Short Squeeze, Breakout and More Instantly...

Stock Investor Wire
RECENT CASI NEWS
  • CASI - CASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 Revenues And Provides Business Updates

    CASI Pharmaceuticals Announces Preliminary Fourth Quarter And Full-Year 2020 Revenues And Provides Business Updates ~ Expects to Report EVOMELA® (melphalan for injection) Fourth Quarter 2020 Unaudited Revenue of Approximately $4.8 Million and Full-Year 2020 Unaudited Revenu...

  • CASI - CASI Pharmaceuticals Partner, BioInvent, Presents Phase I/IIA Data That Suggests BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkin's Lymphoma Patients

    CASI Pharmaceuticals Partner, BioInvent, Presents Phase I/IIA Data That Suggests BI-1206 Restores Activity Of Rituximab In Relapsed Non-Hodgkin's Lymphoma Patients -Responses in 6 out of 9 patients evaluated provide exciting evidence that BI-1206 has the potential to restore act...

  • CASI - Top Penny Stocks On Robinhood If Biotech Is Your Focus Right Now

    Nasdaq & NYSE Penny Stocks To Watch This Week We always talk about following trends when it comes to penny stocks . It might be a niche like electric vehicles or an entire sector like biotech. On this note, the latter has been one of the hottest corners of the stock market today...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your Twitter Account

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.



Sign up or login to continue

Sign up or login to continue.


Forgot password?




WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2020 Market Wire News